ACAD
ACAD
NASDAQ · Biotechnology

Acadia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$26.40
-0.90 (-3.28%)
As of Sep 21, 8:50 PM ET ·
ACAD News1 articles
Acadia Pharma Governance Overhaul Approved, No Cash for Shareholders
Acadia Pharmaceuticals' derivative settlement brings four years of governance reforms, not cash payouts. A federal court will consider final approval in January 2027.
Regulation